Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

ARPO
Aerpio Pharmaceuticals, Inc. Common Stock
stock NASDAQ

Inactive
Aug 26, 2021
2.20USD-0.901%(-0.02)826,006
Pre-market
0.00USD-100.000%(-2.22)0
After-hours
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Oct 5, 2021
10:52AM EDT  Aerpio Pharma US Patent & Trademark Office Abstract For Co.'s 'Humanized monoclonal antibodies that target VE-PTP'   Benzinga
Aug 26, 2021
04:05PM EDT  Aadi Bioscience Announces Closing of Merger with Aerpio   GlobeNewswire Inc
Aug 23, 2021
04:33PM EDT  RA Capital Management Reports In 13G Filing A 5.22% Stake In Aerpio Pharmaceuticals   Benzinga
Aug 11, 2021
04:11PM EDT  Aerpio Pharmaceuticals Q2 EPS $(0.09) Down From $0.23 YoY   Benzinga
04:10PM EDT  -- Ended second quarter 2021 with $36.8 million in cash and cash equivalents -- On May 16, 2021, Aerpio entered into an agreement and plan of merger with Aadi Bioscience, Inc., which is subject to the approval of Aerpio shareholders and other customary closing conditions   GlobeNewswire Inc
Jul 9, 2021
07:36AM EDT  The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO   Benzinga
Jul 8, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2021   Benzinga
06:11AM EDT  HC Wainwright & Co. Upgrades Aerpio Pharmaceuticals to Buy, Announces $22 Price Target   Benzinga
Jun 24, 2021
12:26PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds ARPO, ONDS, CHMA, and PFOH   GlobeNewswire Inc
Jun 17, 2021
10:41AM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds MFNC, CORE, ALTA, and ARPO   GlobeNewswire Inc
Jun 10, 2021
12:18PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds CORE, ALTA, ARPO, and ONDS   GlobeNewswire Inc
Jun 4, 2021
09:23AM EDT  Aerpio Provides Second Update On Aadi Bioscience Presentation At ASCO 2021 Virtual Meeting   Benzinga
09:15AM EDT  Aerpio Provides Second Update on Aadi Bioscience Presentation at   GlobeNewswire Inc
Jun 3, 2021
12:45PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds CORE, ALTA, ARPO, and ONDS   GlobeNewswire Inc
May 26, 2021
05:09PM EDT  Point72 Asset Management Reports In 13G Filing A 3.9% Stake In Aerpio Pharmaceuticals   Benzinga
03:23PM EDT  SHAREHOLDER ALERT: WeissLaw LLP Reminds CORE, ALTA, ARPO, and ONDS   GlobeNewswire Inc
May 20, 2021
09:43PM EDT  AERPIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerpio Pharmaceuticals, Inc. - ARPO   Business Wire
10:13AM EDT  Mid-Morning Market Update: Markets Rise; Hormel Foods Beats Q2 Views   Benzinga
May 19, 2021
07:52PM EDT  Aerpio Provides Update on Aadi Bioscience Presentation at the ASCO   GlobeNewswire Inc
May 18, 2021
06:48AM EDT  Aerpio's Razuprotafib Can Help Against Blood Vessel Dysfunction In COVID-19 Patients   Benzinga
May 17, 2021
03:42PM EDT  Aerpio Pharma Shares Relatively Quiet As Traders Circulate medRxiv Abstract For Co.'s 'Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19'   Benzinga
09:26AM EDT  Aerpio Pharmaceuticals Announces Reverse Merger Agreement With Aadi Bioscience   Benzinga
08:12AM EDT  Aerpio Pharmaceuticals Q1 EPS $(0.09) Up From $(0.10) YoY   Benzinga
08:00AM EDT  -- Ended first quarter 2021 with $39.0 million in cash and cash equivalents -- Subsequent to March 31, 2021, Aerpio entered into an agreement and plan of merger with Aadi Bioscience, Inc.   GlobeNewswire Inc
07:07AM EDT  Aerpio, Aadi Bioscience Enter Merger Deal; Following Merger, Aerpio To Change Its Name To "Aadi Bioscience, Inc."   RTTNews
07:01AM EDT  Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive Merger Agreement; Financial Terms Not Disclosed   Benzinga
07:00AM EDT  Aerpio Pharmaceuticals and Aadi Bioscience Enter into a Definitive   GlobeNewswire Inc
06:59AM EDT  Aerpio Pharmaceuticals Shares Halted; News Pending   Benzinga
May 6, 2021
11:07AM EDT  Aerpio Pharma US Patent & Trademark Office Abstract For Co.'s 'HPTP-BETA INHIBITORS'   Benzinga
Apr 8, 2021
04:35PM EDT  Aerpio Pharma S-3 Shows Registration For $150M Mixed Securities Shelf Offering   Benzinga
Mar 11, 2021
08:06AM EST  Aerpio Pharmaceuticals Q4 EPS $(0.10) Up From $(0.11) YoY   Benzinga
08:00AM EST  Aerpio Reports Fourth Quarter and Full Year 2020 Financial Results   GlobeNewswire Inc
Mar 5, 2021
09:28AM EST  Aerpio Pharmaceuticals' Razuprotafib Dropped From Collaborative COVID-19 Trial   Benzinga
08:03AM EST  Aerpio PharmaceuticalsAnnounces Quantum Leap Healthcare Collaborative, The Sponsor Of Aerpio's I-SPY COVID Trial Of Razuprotafib, Will Discontinue The Testing; QLHC Cited Challenges With Administering Trial   Benzinga
08:00AM EST  Quantum Leap Healthcare Collaborative (QLHC), the sponsor of the I-SPY COVID Trial, will not proceed with further testing of the Aerpio Pharmaceuticals (Nasdaq: ARPO)drug, razuprotafib. Razuprotafib was chosen for testing in the I-SPY COVID Trial because it is hypothesized to stabilize and repair the blood vessels in the lung and improve gas exchange.   GlobeNewswire Inc
Feb 23, 2021
02:48PM EST  Aerpio Pharma Shares Tick Higher Following Circulation Of European Patent Office Doc For Co.'s 'ACTIVATORS OF TIE-2 FOR USE IN TREATING INTRAOCULAR PRESSURE'   Benzinga
Jan 19, 2021
05:28AM EST  Aerpio Pharmaceuticals Issued U.S. Patent 10,894,824 'Multispecific antibodies that target HPTP-.beta. (VE-PTP) and VEGF'   Benzinga
Jan 6, 2021
07:31AM EST  The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping   Benzinga
Jan 5, 2021
04:03PM EST  Aerpio Shares To Resume Trade At 4:30 p.m. EST   Benzinga
04:02PM EST  UPDATE: Aerpio Says Will Consider 'partnering its programs, as well as, the potential for an acquisition, company sale, merger, business combination, asset sale, in-license, out-license or other strategic transaction'   Benzinga
04:01PM EST  Aeropio Reports Strategic Review Following Topline Results From Razuprotafib Phase 2 Trial   Benzinga
04:01PM EST  Aerpio Announces Strategic Review after Topline Results from   GlobeNewswire Inc
Dec 14, 2020
02:33PM EST  Mid-Afternoon Market Update: Dow Turns Negative; Arvinas Shares Spike Higher   Benzinga
02:32PM EST  Mid-Afternoon Market Update: Dow Turns Lower; Arvinas Shares Spike Higher   Benzinga
12:08PM EST  Mid-Day Market Update: Nasdaq Rises 1.1%; Aerpio Pharmaceuticals Shares Plummet   Benzinga
10:14AM EST  Mid-Morning Market Update: Markets Open Higher; FDA Authorizes Pfizer-BioNTech Covid-19 Vaccine   Benzinga
06:21AM EST  HC Wainwright & Co. Maintains Neutral on Aerpio Pharmaceuticals, Lowers Price Target to $1.5   Benzinga
Dec 11, 2020
05:02PM EST  Aerpio Announces Statistically Significant Topline Results from Razuprotafib Glaucoma Phase 2 Trial   Benzinga
05:00PM EST  Primary endpoint achieved with twice-daily dose group at 28 day time point versus latanoprost control group.   GlobeNewswire Inc
Dec 10, 2020
07:42AM EST  The Daily Biotech Pulse: Key Vaccine Adcom Review For Pfizer-BioNTech, Puma, Immutep, G1 Rally On Breast Cancer Conference Presentations   Benzinga
Nov 18, 2020
07:30AM EST  The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted   Benzinga
Nov 10, 2020
11:49AM EST  Why Aerpio's Stock Is Trading Lower Today   Benzinga
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
08:03AM EST  Aerpio Pharmaceuticals Q3 EPS $(0.12) Down From $(0.11) YoY   Benzinga
08:00AM EST  Aerpio Reports Third Quarter 2020 Financial Results and Provides   GlobeNewswire Inc
Nov 8, 2020
03:58PM EST  The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions   Benzinga
12:47PM EST  The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs   Benzinga
Oct 27, 2020
08:25AM EDT  The Daily Biotech Pulse: Catabasis Halts Duchenne Muscular Dystrophy Study, Lilly's COVID-19 Trial Disappointment, Merck, Pfizer Earnings   Benzinga
Oct 26, 2020
05:06PM EDT  11 Stocks Moving In Monday's After-Hours Session   Benzinga
04:04PM EDT  Aerpio Announces The Dosing Of The First Patient With Razuprotafib In The Phase 2 Trial For The Prevention And Treatment Of ARDS In Patients With Moderate-to-Severe Coronavirus   Benzinga
04:01PM EDT  The trial in moderate-to-severe patients is Aerpios second clinical trial in COVID-19 patients and is funded in part by the U.S. military   GlobeNewswire Inc
Sep 22, 2020
03:03PM EDT  Aerpio Shares See Volume; Report Published Titled 'University of Cincinnati researchers to study the effects of razuprotafib on COVID-19 patients,' BZ NOTE: Aerpio Makes Razuprotafib   Benzinga
Sep 17, 2020
07:01AM EDT  Aravive Appoints Michael W. Rogers to Board of Directors   GlobeNewswire Inc
Sep 15, 2020
08:47AM EDT  Aerpio Says Enrollment Completed In 28-Day Phase 2 Razuprotafib Glaucoma Trial   RTTNews
08:32AM EDT  Aerpio Announces Enrollment Completed In The 28-Day Phase 2 Razuprotafib Glaucoma Trial   Benzinga
08:30AM EDT  Aerpio Announces Enrollment Completed in the 28-Day Phase 2   GlobeNewswire Inc
Sep 1, 2020
04:31PM EDT  Aerpio and Quantum Leap Announce First Patients Dosed with Razuprotafib in the   PR Newswire
04:30PM EDT  Aerpio And Quantum Leap Announce First Patients Dosed With Razuprotafib In I-SPY COVID Trial To Treat ARDS In Critically-ill COVID-19 Patients   Benzinga
04:30PM EDT  Aerpio and Quantum Leap Announce First Patients Dosed with   GlobeNewswire Inc
Aug 14, 2020
08:26AM EDT  The Daily Biotech Pulse: Adcom Rules In Favor Of Mesoblast, CureVac IPO, Novavax Clinches UK COVID-19 Vaccine Deal   Benzinga
Aug 13, 2020
06:53AM EDT  HC Wainwright & Co. Maintains Neutral on Aerpio Pharmaceuticals, Raises Price Target to $2   Benzinga
Aug 12, 2020
08:10AM EDT  Aerpio Pharmaceuticals Q2 EPS $0.23 Up From $(0.14) YoY   Benzinga
08:00AM EDT  -- Initiated a Phase 2 Open Angle Glaucoma Trial; Recruiting Ahead of Schedule -- Announced Partnership with I-SPY to Participate in a Clinical Trial to Treat ARDS in COVID-19 Patients -- Announced a Second Clinical Trial Funded in Part by the U.S. Military to Prevent ARDS in COVID-19 Patients -- Ended Second Quarter 2020 with $44.9 Million in Cash   GlobeNewswire Inc
04:21AM EDT  Earnings Scheduled For August 12, 2020   Benzinga
Aug 10, 2020
08:00AM EDT  Aerpio Pharmaceuticals to Report Second Quarter 2020 Financial   GlobeNewswire Inc
Aug 6, 2020
07:57AM EDT  The Daily Biotech Pulse: FDA Nod For GlaxoSmithKline, Bristol-Myers Squibb Earnings, Acutus Medical IPO   Benzinga
07:19AM EDT  Biocryst Pharmaceuticals Q2 EPS $(0.24) Beats $(0.25) Estimate   Benzinga
Aug 4, 2020
04:57PM EDT  Aerpio Pharmaceuticals Announces A Second Clinical Trial With Funding From MTEC To Evaluate Razuprotafib For The Prevention And Treatment Of ARDS In Patients With Moderate To Severe Coronavirus   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC